REFERENCES

1. Antman EM, Wenger TL, Butler VP, et al: Treatment of 150 cases of life-threatening digitalis intoxication with digoxin- specific F(ab) antibody fragments. Circulation 1990; 81:1744- 52.
2. Hickey AR, Wegner TL, Carpenter VP, et al: Digoxin immune F(ab) therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 1991; 17:590-98.
3. Kelly RA, Smith TW: Recognition and management of digitalis toxicity. Am J Cardiol 1992; 69: 108G-119G.
4. Lewis RP: Clinical use of serum digoxin concentrations. Am J Cardiol 1992; 69:97G-107G
5. Smith TW, Haber E, Yeatment L, et al: Reversal of advanced digoxin intoxication with Fab fragments of digoxin specific antibodies. N Eng J Med 1976; 294:797-800.
6. Taboulet P, Baud FJ, Bismuth C: Clinical features and management of digitalis poisoning- rationale for immuno therapy. Clin Toxicol 1993; 31(2): 247-260.
7. Woolf A: Revising the management of digitalis poisoning. Clin Toxicol 1993; 31(2): 247-260.
8. Doyon S, Roberts JR: The use of glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22:1229.
9. Pollack CV: Utility of glucagon in the emergency department J Emerg Med 1993; 11:195.
10. Ramoska EA, Spiller HA, Winter M, et al: A one year evaluation of calcium channel blocker overdose-induced toxicity and treatment. Ann Emerg Med 1993;22: 196-200.
11. Wolf LR: The use of amrinone and glucagon in a case of calcium channel blocker overdose, An Emerg Med 1993;22:1225.

Back to Toxikon Case Studies